Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54
- 1 September 2017
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 70 (11), 1368-1375
- https://doi.org/10.1016/j.jacc.2017.07.768
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54European Heart Journal, 2015
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial InfarctionThe New England Journal of Medicine, 2015
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspectiveEuropean Heart Journal, 2015
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary SyndromesJournal of the American College of Cardiology, 2014
- Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trialAmerican Heart Journal, 2014
- Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With AtherothrombosisJAMA, 2010
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsThe New England Journal of Medicine, 2006
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Survival analysis in natural history studies of diseaseStatistics in Medicine, 1989
- A note on the product-limit estimator under right censoring and left truncationBiometrika, 1987